# Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

> **NCT03670173** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Osalmid

## Key facts

- **NCT ID:** NCT03670173
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-01
- **Primary completion:** 2021-05-18
- **Final completion:** 2021-05-18
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03670173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03670173, "Safety and Efficacy Assessments of Osalmid in Multiple Myeloma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03670173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*